Boehringer Ingelheim (BI) is among the 23 manufacturers that currently restrict contract pharmacy relationships with covered entities. It is also the 16th manufacturer to broaden its restrictions on contract pharmacies following the…
View Here: Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary 6.21.23
PRESS STATEMENT: FOR IMMEDIATE RELEASE June 20, 2023 National Ryan White Clinic Organization Fires Back at Gilead-Funded “Study” Riddled with Inaccuracies, Faulty Assumptions, and Profit-Centered Analysis The…
Novo Nordisk Tightens Restrictions on 340B Drugs Dispensed by Contract Pharmacies; Organon Becomes the 22nd Manufacturer to Issue Restrictions On June 1, 2023, Novo Nordisk and Organon each announced restrictions…